electroCore Taps Microsoft Veteran to Drive Strategic Growth on Board

On August 1, 2025, electroCore, Inc., a commercial-stage bioelectronic medicine and wellness company, announced the appointment of James C. Theofilos to its Board of Directors. Theofilos, who has been a Senior Finance Manager at Microsoft Corporation since October 2023, expressed his honor at joining the electroCore board.

Theofilos has a long history with the company, as the Theofilos family has been an early investor and founding partner of electroCore for nearly two decades. In his role at Microsoft, Theofilos has served as the global finance lead for the company's healthcare and life sciences business, working alongside major providers, payers, and pharmaceutical companies to bring innovative, data-driven solutions to market.

Now, Theofilos aims to bring that same strategic growth mindset, AI-driven innovation, and operational discipline to electroCore. He believes this will help the company scale its impact and unlock new opportunities to drive long-term shareholder value. With Theofilos' extensive experience in the healthcare and technology sectors, electroCore is poised to accelerate its growth and further establish itself as a leader in the bioelectronic medicine space.